FRONTAGE

1521
2.0800.73% ( +0.015 )
Delay Closed: Nov 17, 16:08:15

Profile

About

FRONTAGE
FRONTAGE
01521.HK

Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, and regulatory support. In addition, it offers pharmaceutical product development services, including intermediate and active pharmaceutical ingredient (API) synthesis, process and formulation development, and clinical trial material manufacturing.

Profile

Company Name
Frontage Holdings Corporation
Market
SEHK
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management